‘You Only Look Once’ helps detect, classify lesions on deceptively normal screening mammograms

Researchers have combined three emerging technologies to detect and classify breast cancers found in follow-up imaging of women whose recent screening mammography was deemed normal.

The team proposes their innovative use of the technologies—deep learning, digital image processing and image-to-image translation—as a way to alert radiologists when breast tissue appears normal at screening but is, in fact, at heightened risk for soon developing cancer.

The work was carried out at the University of Louisville and is described in the June edition of Computer Methods and Programs in Biomedicine [1].

Computer scientists and engineers Asma Baccouche, PhD (candidate), Adel Elmaghraby, PhD, and colleagues built and tested their system using several hundred DICOM images from a private digital mammography database.

They worked with two existing forms of You Only Look Once (aka “YOLO”) image-translation software, CycleGAN and Pix2Pix, to render synthetic mammograms from priors. With these they customized models to diagnose masses, calcifications and architectural distortions as well as identify normal tissue.

For the study, all prior mammograms, most of which were acquired one year before the follow-up, had been reported as normal. All the follow-ups, or “current” studies, were either biopsy-confirmed cancerous or healthy.

Baccouche and colleagues found their system detected and classified breast lesions on the current mammograms with as high as 93% accuracy for masses, 88% for calcifications and 95% for architectural distortions. The system correctly classified normal mammograms with 92% accuracy for current exams and 90% for priors.

Noting the present study builds on the team’s previous research, the authors state they continued the project to “integrate the prior mammograms from all used follow-up screenings and provide an early detection and classification on initial screened mammograms.”

The new work, they add, “emphasize[s] the ability of a possible retrospective prediction on prior mammograms that were diagnosed as normal but at a later stage, they were reported with a clear presence and progress of abnormal findings.”

Baccouche and co-authors cite prior research showing that, thanks to an increase in follow-ups and screenings during diagnosis periods, close to 50% of prior mammograms end up retrospectively presenting lesions that were initially missed.

More from their discussion section:

[T]he contribution of this paper could be utilized to screen prior mammograms and detect those with the highest abnormal risk of breast cancer. Consequently, it will provide a warning signal for radiologists to forecast and anticipate the cancer progress.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup